The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C01 | Cardiac therapy | |
| 3 | C01D | Vasodilators used in cardiac diseases | |
| 4 | C01DA | Organic nitrates | |
| 5 | C01DA14 | Isosorbide mononitrate |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 40 mg |
| Active Ingredient | Description | |
|---|---|---|
| Isosorbide mononitrate |
Isosorbide mononitrate is an organic nitrate, which, in common with other cardioactive nitrates, is a vasodilator. It produces decreased left and right ventricular end-diastolic pressures to a greater extent than the decrease in systemic arterial pressure, thereby reducing afterload and especially the preload of the heart. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CARMIL XL Prolonged release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ELANTAN LA Prolonged release capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ISMO Retard prolonged-release tablet | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC | |
| ISOMONIT Prolonged release tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| ISOSORBIDE MONONITRATE / CARMIL / MONOMIL Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MONOREM Prolonged-release tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| MONOREM Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| NYZAMAC Prolonged-release capsule, hard | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
